Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer. (2013)
Attributed to:
Delivery of a GMP cryogenic cold chain for clinical delivery of regenerative medicine therapeutics.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hgtb.2013.022
PubMed Identifier: 23931270
Publication URI: http://europepmc.org/abstract/MED/23931270
Type: Journal Article/Review
Volume: 24
Parent Publication: Human gene therapy methods
Issue: 5
ISSN: 1946-6536